ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2019 ACR/ARP Annual Meeting

November 8-13, 2019. Atlanta, GA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 560
    Dactylitis Occurrence in Early Spondyloarthritis: Five Years Data from a French National Prospective Cohort
  • Abstract Number: 1277
    Damage and Comorbidities in a Cohort of Patients with Idiopathic Inflammatory Myopathy
  • Abstract Number: 769
    Damage in Takayasu‘s Arteritis Is Associated with Age at Symptom-onset, Disease-duration and Corticosteroid Dose but Not Relapse in Routine Follow-up
  • Abstract Number: 1356
    DAS28-CRP Cut-offs for High Disease Activity Assessment Is Lower Than DAS28-ESR in Rheumatoid Arthritis
  • Abstract Number: 2435
    Data Driven Prediction Lymphoma Model and 10-year Overall Survival Rates of a Large Harmonized Cohort of Patients with Primary Sjögren’s Syndrome Associated Lymphomas
  • Abstract Number: 2857
    Decision Tree Analysis to Identify Inflammatory Arthritis Patient Subgroups with Different Levels of Treatment Persistence with First-Line Subcutaneous TNF-alpha Inhibitors
  • Abstract Number: 2731
    Decomposition Analysis of Spending and Price Trends for Biologic Anti-Rheumatic Drugs in Medicare and Medicaid
  • Abstract Number: 644
    Decreased HVEM Expression in Lupus Patients and Impact of HVEM Knockout Mouse Model of Lupus Suggest a Role for BTLA Signaling in Disease Pathogenesis
  • Abstract Number: 476
    Decreased Muscle Mass, a Novel Predicting Indicator for One-year Radiographic Progression in Rheumatoid Arthritis: A Real-world Cohort Study
  • Abstract Number: 1561
    Decreased Nocturnal Blood Pressure Dipping in Patients with Systemic Lupus Erythematosus: Association with Markers of Inflammation
  • Abstract Number: 1159
    Deep Learning Social Media Analysis Demonstrated Gender-Specific Disparity in Side Effects from Rheumatoid Medications
  • Abstract Number: 2561
    Deep Remission During Induction Therapy for Lupus Nephritis Prevents Damage Accrual and Associates with the Baseline Proportions of Peripheral Treg, CD8+ T Cells, and NKT-like Cells
  • Abstract Number: 116
    Defective EZH2 Expression Attenuates Treg Differentiation in Rheumatoid Arthritis
  • Abstract Number: 1789
    Defibrotide Inhibits Antiphospholipid Antibody-Mediated NET Release and Endothelial Cell Activation
  • Abstract Number: 1358
    Defining Minimal Clinically Important Changes for the Patient Activity Scale-II
  • Abstract Number: 1592
    Defining the SLE-Associated Pulmonary Arterial Hypertension Phenotype
  • Abstract Number: 299
    Definition of New Ultrasound Enthesophytes Score: Application in a Consecutive Series of IBD Patients
  • Abstract Number: 2854
    Delay Between the Onset of Psoriasis and Arthritis in PsA Patients from the PsART International Cohort
  • Abstract Number: 1187
    Delayed Gadolinium-enhanced MR Imaging of Cartilage – A Pilot Study to Measure the Effect of Adalimumab Plus MTX versus Placebo Plus MTX on Cartilage in Early RA Patients (CAR-ERA-Study)
  • Abstract Number: 1812
    Delineating Early Response Trajectories to Biologics in Polyarticular Course Juvenile Idiopathic Arthritis
  • Abstract Number: 717
    Dental Health in Systemic Sclerosis Patients Risk Factors and Comorbidities
  • Abstract Number: 1741
    Depression and Anxiety Symptoms in Childhood-Onset Systemic Lupus Erythematosus
  • Abstract Number: 2822
    Depression and Subsequent Risk for Incident Seronegative Rheumatoid Arthritis Among Women
  • Abstract Number: 913
    Depression as a Moderator of Analgesic Effectiveness in Knee Osteoarthritis
  • Abstract Number: 2172
    Depression of Vitamin D Levels After Adult Primary Posterior Spinal Fusion: Are We Adding Insult to Injury?
  • Abstract Number: 178
    Depression: A Common Comorbidity in Rheumatic Diseases. a Case-Control Study
  • Abstract Number: 339
    Depressive Symptoms Influence Success of Allopurinol in Reducing Serum Urate
  • Abstract Number: 2350
    Derivation and Validation of a Biomarker-Based Cardiovascular Risk Prediction Score in Rheumatoid Arthritis
  • Abstract Number: 2888
    Deriving Accurate Prednisone Dosing from Electronic Health Records: Analysis of a Natural Language Processing Tool for Complex Prescription Instructions
  • Abstract Number: 67
    Dermal Lymphatic Dysfunction Is Associated with Disease Activity in the MRL/lpr Lupus Model
  • Abstract Number: 1826
    Describing Intra-Individual Cognitive Function Course over Time in Lupus Patients: Persistent and Fluctuating Cognitive Impairment, Affected Cognitive Domains, and Severity
  • Abstract Number: 259
    Describing Treatment Patterns and Healthcare Costs in Newly Diagnosed Psoriatic Arthritis Patients by Physician Specialty
  • Abstract Number: 2497
    Description and Prevalence of Spondyloarthritis in Unselected Patients with Psoriasis, Acute Anterior Uveitis, and Inflammatory Bowel Disease Presenting with Undiagnosed Back Pain
  • Abstract Number: 1793
    Descriptive Analysis of Biopsy-proven Antiphospholipid Antibody-associated Nephropathy Patients Included in the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
  • Abstract Number: 2173
    Descriptive Analysis of Patient-Reported Home Exercise and Physical Activity and Their Associations with Patient Baseline Characteristics Following Total Knee Replacement
  • Abstract Number: 2552
    Design and Development of an Online Intervention for Lupus Self-Management Based on the Transtheoretical Model of Change
  • Abstract Number: 1680
    Design of a Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of 2 Different Dose Regimens of IFX-1, a C5a Inhibitor, as an Add-On Therapy for Granulomatosis with Polyangiitis or Microscopic Polyangiitis
  • Abstract Number: 255
    Designing and Testing Treat to Target as a New Care Model in JIA Across a Network of Pediatric Rheumatology Centers
  • Abstract Number: 2430
    Detection and Clinical Significance of Circulating M3 Muscarinic Acetylcholine Receptor Reactive Th17 Cells in Patients with Primary Sjögren’s Syndrome
  • Abstract Number: 2310
    Determinants of Cognitive Function in Rheumatoid Arthritis (RA) Patients
  • Abstract Number: 237
    Determination of Muscle Pressure in Patients with Fibromyalgia by Two Examiners; The Examiners Get Similar Results
  • Abstract Number: 1965
    Determining a Polygenic Risk Score in Pediatric Systemic Lupus Erythematosus
  • Abstract Number: 747
    Detrimental Factors Affecting the First-year Clinical Response in Korean Patients with Polymyalgia Rheumatica
  • Abstract Number: 267
    Develop Risk Prediction Model and Drug Withdrawl Road Map Through Pattern Extraction and Data Mining: Create a Master Algorithm from the Smart System of Disease Management (SSDM)
  • Abstract Number: 2201
    Developing a Comprehensive Patient-Specific Disease Progression Prediction Model for Knee Osteoarthritis Using Machine/Deep Learning Methods
  • Abstract Number: 916
    Development and Initial Validation of the MS Score for Diagnosis of Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis
  • Abstract Number: 915
    Development and Initial Validation of the Systemic JADAS, a New Composite Disease Activity Score for Systemic Juvenile Idiopathic Arthritis
  • Abstract Number: 2666
    Development and Outcome of Aortic Complications During Tocilizumab (TCZ) Treatment of GCA and Histopathologic Evidence of Residual Inflammation
  • Abstract Number: 2750
    Development and Preliminary Validation of a Novel Lung Ultrasound Interpretation Criteria for the Detection of Interstitial Lung Disease in Patients with Systemic Sclerosis
  • Abstract Number: 168
    Development and Usability Testing of Take Charge: An Email Series to Increase Knowledge of Self-Management Skills in People with Lupus
  • Abstract Number: 1176
    Development and Validation of a Preliminary MRI Sacroiliac Joint Composite Structural Damage Score in a 5-year Longitudinal Study of Patients with Axial Spondyloarthritis
  • Abstract Number: 2516
    Development of a Biomarker Panel for Prediction of Disease Flares in Systemic Lupus Erythematosus
  • Abstract Number: 1919
    Development of a Multi-Modality Imaging Approach to Evaluate Lupus Nephritis
  • Abstract Number: 341
    Development of a Multivariable Improvement Measure for Gout
  • Abstract Number: 990
    Development of a Novel Anti TNF-Steroid Antibody Drug Conjugate That Shows Promising Efficacy at Doses That Avoid Steroid Side Effects in a Mouse Model of Rheumatoid Arthritis
  • Abstract Number: 562
    Development of a Set of ASAS Quality Standards for Adults with Axial Spondyloarthritis
  • Abstract Number: 1101
    Development of an Algorithm to Identify Sjögren’s Syndrome Patients in the French National Healthcare Claims Database
  • Abstract Number: 601
    Development of an Optimized Online Self-Referral Tool for Early Recognition of Patients with Axial Spondyloarthritis – Data from the OptiRef Study
  • Abstract Number: 1580
    Development of Comorbidity in Danish Nationwide Cohort of Newly Diagnosed Patients with Systemic Lupus Erythematosus
  • Abstract Number: 798
    Development of Large Vessel Vasculitis Including Aortitis in a Patient with Deficiency of the IL-1 Receptor Antagonist (DIRA) Points to Converging Roles of IL-1 and TNF in Vascular Pathogenesis Recapitulating Findings from a Murine Model
  • Abstract Number: 1698
    Development of Machine Learning Models (Artificial Neural Networks) for Prediction of Vision Threatening Behçet’s Disease
  • Abstract Number: 145
    Development of New International Classification Criteria for Antiphospholipid Syndrome: Phase II Results
  • Abstract Number: 1109
    Development of Smart-phone Spondyloarthritis Management System and Real-world Study of Chinese Patients with Ankylosing Spondylitis
  • Abstract Number: 1758
    Development of Ultrasound Detectable Arthritis Among ACPA Positive Subjects with Musculoskeletal Symptoms: The Risk RA Prospective Study
  • Abstract Number: 2217
    DEXA Does Not Accurately Reflect FRAX Score in Patients with Autoimmune Disease on Corticosteroids
  • Abstract Number: 718
    Diagnosing Pulmonary Hypertension Using the Proposed 6th World Symposium on Pulmonary Hypertensions New Definitions
  • Abstract Number: 832
    Diagnosis of Fibromyalgia: Comparison of AAPT and ACR Criteria
  • Abstract Number: 2127
    Diagnosis of Inflammatory Rheumatic Diseases: Preliminary Approach by Urine Metabolomics
  • Abstract Number: 723
    Diagnosis of Systemic Sclerosis: How and When
  • Abstract Number: 633
    Diagnostic Delay in Spondyloarthritis
  • Abstract Number: 491
    Diagnostic Performance of Anti-cyclic Citrullinated Peptide (CCP) 2 and CCP3.1 Assays in Early Rheumatoid Arthritis
  • Abstract Number: 559
    Diagnostic Utility of Individual Inflammatory Back Pain Parameters in Patients with Axial Spondyloarthritis
  • Abstract Number: 193
    Diet as a Risk Factor for Rheumatoid Arthritis
  • Abstract Number: 829
    Dietary Intake Does Not Explain Microbiome Alterations or Symptom Severity in Fibromyalgia
  • Abstract Number: 2927
    Dietary Patterns and Symptomatic Progression of Knee Osteoarthritis: Data from the Osteoarthritis Initiative
  • Abstract Number: 89
    Difference of Induced CD4+ and Natural Regulatory T Cells in Targeting Inflamed Synovial Tissues in Autoimmune Arthritis
  • Abstract Number: 2482
    Differences and Similarities According to Gender in Patients with Psoriatic Arthritis Initiating Biological Therapy
  • Abstract Number: 783
    Differences in Chromatin Architecture in Treatment Naïve Pediatric Lupus Patients
  • Abstract Number: 2489
    Differences in Clinical Characteristics, Quality of Life, Disability, and Work Productivity in Psoriatic Arthritis Patients by Gender: Findings from a Cross-sectional Survey in the US and Europe
  • Abstract Number: 1156
    Differences in Clinical Outcomes According to the Healthcare Regime in Colombian Patients with Rheumatoid Arthritis
  • Abstract Number: 425
    Differences in Correlation Between Objective Disease Measurements and Patient’s/physician’s Global Assessment in the Large Non-interventional Study SUSTAIN
  • Abstract Number: 2229
    Differences in Fracture Risk Assessment (FRAX) and Osteoporosis Treatment Cutoffs with and Without Bone Mineral Density Are Greater in Anti-Cyclic Citrullinated Peptide Positive Rheumatoid Arthritis
  • Abstract Number: 2090
    Differences in Stepping and Standing Based on Self-reported Exercise Identity in Persons Following Total Knee Replacement
  • Abstract Number: 2818
    Differences in the Phenotypic Landscape and Antigen Specificity of CD4+ T Cells Are Present in CCP+ Subjects Before the Onset of Rheumatoid Arthritis
  • Abstract Number: 1268
    Different Colchicine Preparations for Familial Mediterranean Fever: Are They the Same?
  • Abstract Number: 1839
    Different Patterns and Specific Outcomes of Large-Vessel Involvements in Giant Cell Arteritis
  • Abstract Number: 2598
    Different Treatment Backgrounds Do Not Influence Aminaphtone Efficacy in Primary and Secondary Raynaud’s Phenomenon
  • Abstract Number: 2504
    Differential Expression of Human Endogenous Retroviruses in Psoriatic Disease
  • Abstract Number: 2738
    Differential Methylation of Peripheral Blood Adaptive Immune Cells in Individuals at High Risk for RA and with Early RA Compared with Controls Identifies Pathways Important in Transition to Arthritis
  • Abstract Number: 697
    Differing Opinions on Clinical Research Between Healthcare Providers and Lupus Patients
  • Abstract Number: 726
    Digital Blood Perfusion Differences Between Black Africans and Caucasians with Systemic Sclerosis
  • Abstract Number: 2746
    Dimethyl Fumarate Ameliorates the GATA6 Deficiency-Induced Pulmonary Hypertension by Normalizing Oxidative and ER Stress
  • Abstract Number: 659
    Diminished Memory B-cells in Systemic Lupus Erythematosus Patients with Low Disease Activity
  • Abstract Number: 1129
    Direct Medical and Societal Cost of Opioid Use in Symptomatic Knee Osteoarthritis Patients in the United States
  • Abstract Number: 1598
    Disability Among Subtypes of SLE
  • Abstract Number: 1923
    Disability and Health-Related Quality of Life Outcomes in Patients with Systemic or Polyarticular Juvenile Idiopathic Arthritis Treated with Tocilizumab in Randomized Controlled Phase 3 Trials
  • Abstract Number: 1438
    Discontinuation of Concomitant Methotrexate in Japanese Patients with Rheumatoid Arthritis Treated with Tocilizumab: An Interventional Study
  • Abstract Number: 521
    Discontinuation of Disease Modifying Drugs Due to Inefficacy in Patients with Incident Rheumatoid Arthritis
  • Abstract Number: 2370
    Discontinuation of Disease Modifying Drugs in Patients with Incident Rheumatoid Arthritis
  • Abstract Number: 1385
    Discontinuation of Oral Glucocorticoid After Initiation of Biological DMARDs Due to a Higher Dose of Methotrexate; A Retrospective Observational Study Based on Data from a Japanese Multicenter Registry Study
  • Abstract Number: 965
    Discovery of DWP212525, a Potent JAK3 and BTK Dual Target Inhibitor for the Treatment of Autoimmune Diseases
  • Abstract Number: 36
    Discovery, Verification and Validation of Rheumatoid Arthritis Activity Monitoring Biomarkers
  • Abstract Number: 1925
    Discriminant and Predictive Ability of the Parent Version of the Juvenile Arthritis Disease Activity Score in Two Large Multination Cohorts of Patients with Juvenile Idiopathic Arthritis
  • Abstract Number: 1612
    Disease Activity and Cognitive Function in Systemic Lupus Erythematosus
  • Abstract Number: 1588
    Disease Activity and Dysregulated Iron Metabolism: A Potentially Overlooked Mechanism for Anaemia in Patients with Systemic Lupus Erythematosus?
  • Abstract Number: 1726
    Disease Activity and Health Care Utilization Among Young Adults with Childhood-onset Lupus Transitioning to Adult Care: Follow-Up Data from the Pediatric Lupus Outcomes Study
  • Abstract Number: 440
    Disease Activity and Quality of Life in Behçet’s Syndrome: The Role of Patient Reported Outcome
  • Abstract Number: 1725
    Disease Activity in Childhood-Onset Systemic Lupus Erythematosus: Initial Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry
  • Abstract Number: 2515
    Disease Activity Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Psoriatic Artrhitis
  • Abstract Number: 502
    Disease Activity Measures at Baseline and 3 Months as Predictors of Rapid Radiographic Progression in Methotrexate Naïve Patients with Early Rheumatoid Arthritis
  • Abstract Number: 839
    Disease Activity, Cytokine Profiles, and the Risk of Incident Diabetes in Rheumatoid Arthritis
  • Abstract Number: 1699
    Disease Course of Behçet’s Syndrome Patients Not Fulfilling International Study Group Criteria at Presentation
  • Abstract Number: 2292
    Disease Flares of Rheumatoid Arthritis During Pregnancy: What Is the Impact of Stopping bDMARDs at the Beginning of Pregnancy?
  • Abstract Number: 1724
    Disease Manifestations and Impact on Quality of Life in Subjects with Pre-Pubertal Onset Systemic Lupus Erythematosus
  • Abstract Number: 972
    Disease Severity Is Linked to an Increase in Autoantibody Diversity in IgG4-related Disease
  • Abstract Number: 880
    Diseased Lupus Nephritis Kidneys Serve as a Primary Site of Systemic Autoimmune Development
  • Abstract Number: 658
    Disentangling Connective Tissue Diseases: Overlaps and Disparities in Clinical Diagnosis, Classification Criteria and Autoantibodies – Results from the Lupus Extended Autoimmune Phenotype Study
  • Abstract Number: 1980
    Disorganization of Chondrocyte Columns in the Growth Plate During Experimental Osteoarthritis in Mice
  • Abstract Number: 1057
    Dissecting the Cellular Mechanism of Prostacyclin Analog Iloprost in Reversing Vascular Dysfunction in Scleroderma
  • Abstract Number: 1038
    Distinct Cell-bound Complement Activation Signatures Are Observed in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 719
    Distinct Characteristics of the Gut Microbiome of Patients with Systemic Sclerosis and Small Intestinal Bacterial Overgrowth
  • Abstract Number: 2426
    Distinct Clinical Characteristics of Anti-Ro/SSA Negative Primary Sjögren’s Syndrome: Data from a Cohort for Sjögren’s Syndrome in Korea
  • Abstract Number: 385
    Distinctive Clinical Features and Biomarkers of Connective Tissue Disease Associated Interstitial Lung Disease
  • Abstract Number: 1711
    Distinctive Imaging Features Between IgG4-Related Ophthalmic Disease and Graves’ Orbitopathy: A Comparative Study
  • Abstract Number: 2098
    Distinctive Pattern of LTBI Screening Parameters in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) in Endemic Areas
  • Abstract Number: 786
    Distinguishing S100 Proteins and Cytokine Levels Between Active and Inactive Uveitis in Children with Juvenile Idiopathic Arthritis
  • Abstract Number: 2536
    Distribution and Predictors of Whole Blood Hydroxychloroquine Levels in Clinical Rheumatology Practices in the United States
  • Abstract Number: 820
    Diurnal Stability of Transcriptional Profiles in Rheumatoid Arthritis
  • Abstract Number: 1985
    Divergent Mononuclear Cell Participation and Cytokine Release Profiles Define Hip and Knee Osteoarthritis
  • Abstract Number: 493
    Diversity Analysis of Intestinal Flora in Patients with Rheumatoid Arthritis
  • Abstract Number: 1465
    Diversity Analysis of Intestinal Flora in Patients with Sjogren’s Syndrome
  • Abstract Number: 2469
    Diversity of Poly-Functional T Cells in Psoriatic Arthritis and Rheumatoid Arthritis and Its Therapeutic Significance
  • Abstract Number: 2906
    DMARD-free Remission in Established Rheumatoid Arthritis: 2 Year Results of the TARA Trial
  • Abstract Number: 2395
    DMARD-naïve Rheumatoid Arthritis (RA) Patients Have Greater RAPID3 Improvement over 6 Months After 1st Visit Than Patients Who Were Treated Previously Treated with DMARDs, Although Baseline RAPID3 Was Similar: The Importance of Early Treatment
  • Abstract Number: 1030
    DNA Methylation Changes Are Associated with Particulate Matter 2.5 Exposure in SLE Patients
  • Abstract Number: 2396
    DNA Methylation of the Dual Specificity Phosphatase 22 (DUSP22) Gene Promoter in Plasma and Medication Use in Rheumatoid Arthritis (RA)
  • Abstract Number: 789
    DNASE1L3 Variant in Hypocomplementemic Urticarial Vasculitis Syndrome Identifies a Different Clinical Phenotype
  • Abstract Number: 1616
    Do All Antiphospholipid Antibodies Confer the Same Risk for Major Organ Involvement in Systemic Lupus Erythematosus Patients?
  • Abstract Number: 2554
    Do All Patients Who Achieve Lupus Low Disease Activity State Have Similar Outcomes?
  • Abstract Number: 604
    Do Illness Perceptions and Coping Change over Time in Patients Recently Diagnosed with Axial Spondyloarthritis? A 2-Year Follow-Up Study in the SPACE Cohort
  • Abstract Number: 2329
    Do Myocardial Inflammation and Microvascular Dysfunction in RA Lead to Adverse Changes in Left Ventricular Structure and Function over Time? A Longitudinal Analysis of Participants from Rheumatoid Arthritis: Study of the Myocardium
  • Abstract Number: 2836
    Do Serum Urate-associated Genetic Variants Differentially Contribute to Gout Risk According to Body Mass Index? Analysis of the UK Biobank
  • Abstract Number: 1230
    Do Serum Urate-Associated Genetic Variants Influence Gout Risk in People on Diuretics? Analysis of the UK Biobank
  • Abstract Number: 854
    Do Smoking and Socio-economic Factors Independently Influence Imaging Outcomes in Axial Spondyloarthritis? Five-year Data from the DESIR Cohort
  • Abstract Number: 311
    Documenting Bone Health for Veterans with Rheumatoid Arthritis in an Outpatient Academic Clinic: A Multiphase Quality Improvement Project
  • Abstract Number: 205
    Does a Mandatory Non-medical Switch from Originator to Biosimilar Etanercept Lead to Increase in Healthcare Use and Costs? A Danish Register-based Study of 1620 Patients with Inflammatory Arthritis
  • Abstract Number: 1846
    Does Cartilage Loss Cause Pain in Osteoarthritis?
  • Abstract Number: 2404
    Does Combined Therapy Affects Adherence in Rheumatoid Arthritis?
  • Abstract Number: 739
    Does Digital Thermal Monitoring Correlate to Specific Nailfold Videocapillaroscopy Abnormalities?
  • Abstract Number: 837
    Does Discordance Between Baseline Patient’s and Evaluator’s Global Assessment of Disease Activity Impact Retention and Remission Rates of a First TNF Inhibitor in Patients with Axial Spondyloarthritis? Data from the EuroSpA Research Collaboration Network
  • Abstract Number: 1088
    Does Drug Effectiveness of 2nd and 3rd TNF Inhibitors in Patients with Psoriatic Arthritis Depend on the Reason for Withdrawal from the Previous Treatment? – Results from the EuroSpA Research Collaboration
  • Abstract Number: 2799
    Does Early Anterior Cruciate Ligament Reconstruction Prevent Further Meniscal Damage? Secondary Analysis of a Randomized Controlled Trial
  • Abstract Number: 216
    Does Fibromyalgia Change the Evaluation of Spondyloarthritis Activity? A Meta-analysis of Observational Studies
  • Abstract Number: 432
    Does Improvement in Patient Pain and Fatigue Lag Behind Clinical Remission in Rheumatoid Arthritis Patients? Data from a Rheumatoid Arthritis Registry
  • Abstract Number: 2810
    Does Loss-of-function Variants in SAT1 Cause X-linked Pediatric Lupus?
  • Abstract Number: 1676
    Does Pneumocystis Jiroveci Pneumonia (PJP) Prophylaxis Prevent Hospitalizations for Other Infections in Vasculitis Patients?
  • Abstract Number: 1662
    Does PR3-ANCA+ Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss)Really Exist?
  • Abstract Number: 1551
    Does Retention and Remission Rates to 2nd and 3rd TNF Inhibitors in Patients with Axial Spondyloarthritis Depend on the Reason from Withdrawal to the Previous Treatment? – Real World Data from 12 European Countries in the EuroSpA Research Collaboration
  • Abstract Number: 2924
    Does the Degree of Decline in Walking Speed Predict Mortality Risk Beyond the Present Level of Walking Speed in Knee Osteoarthritis?
  • Abstract Number: 289
    Doppler in Entheses: A Potential Useful Outcome in Active Spondyloarthritis and Psoriatic Arthritis
  • Abstract Number: 1153
    Double Trouble: Utility of Serial TB Screening in a Rheumatology Clinic Serving a Foreign-Born Population
  • Abstract Number: 1687
    Dramatic but Suspensive Effect of interleukin-1 Inhibitors on Persistent Urticarial Vasculitis
  • Abstract Number: 586
    Drug Concentrations and Anti-drug Antibodies Influence in Response to Adalimumab: Results from the BioEfficacySpA Clinical Trial
  • Abstract Number: 752
    Drug Retention and Discontinuation Reasons Between Seven Biologics in Patients with Takayasu Arteritis
  • Abstract Number: 2856
    Drug Retention of Biological DMARDs Targeting IL-12/IL-23 or IL-17 versus TNF Inhibitors, After a First Line TNF Inhibitor, in Patients with Psoriatic Arthritis – an Analysis in the Swiss SCQM Register
  • Abstract Number: 1555
    Drug Survival and Safety of Biosimilar CT-P13 versus Reference Infliximab in Patients with Ankylosing Spondylitis: Data from the Korean College of Rheumatology Biologics Registry
  • Abstract Number: 1548
    Drug Survival of Secukinumab for Axial Spondyloarthritis in a Real-World Setting Possible Response Factors
  • Abstract Number: 1511
    Drug Survival of Ustekinumab in Psoriatic Arthritis: A Real-World Multicentric Cohort of 252 Patients
  • Abstract Number: 1713
    Drug-induced IgA Vasculitis: Data from the French Pharmacovigilance Network and the WHO VigiBase
  • Abstract Number: 1458
    Dual Analysis with Nerve Ultrasound and Skin Biopsy in Painful Neuropathy Associated with Sjögren’s Syndrome
  • Abstract Number: 2205
    Dual Femur Bone Density Measurements with Novel Sonographic Approach – Radiofrequency Echographic Multi Spectrometry
  • Abstract Number: 937
    Dual Neutralization of IL-17A and IL-17F with Bimekizumab in Patients with Active Ankylosing Spondylitis: 48-Week Efficacy and Safety Results from a Phase 2b, Randomized, Blinded, Placebo-Controlled, Dose-Ranging Study
  • Abstract Number: 2881
    Dual Neutralization of IL-17A and IL-17F with Bimekizumab in Patients with Active Psoriatic Arthritis: Disease Activity and Remission in a 48-Week Phase 2b, Randomized, Double‑Blind, Placebo-Controlled, Dose-Ranging Study
  • Abstract Number: 231
    Duloxetine for Chronic Pain Management in a Tertiary Care Rheumatology Practice: How Patients Are Doing in the Real World
  • Abstract Number: 1384
    Duration of Oral Corticosteroid Therapy Does Not Change with the Addition of a Parenteral Injection: Results from a Real-World Canadian Early RA Cohort
  • Abstract Number: 1025
    Dynamic Changes During SLE Flare Implicate Age-Associated B Cells and Altered T Follicular and Peripheral Helper Cell Responses in Disease Activity
  • Abstract Number: 754
    Dynamic Distribution and Phenotype Shift from M1 to M2 of Macrophages in Vascular Lesions of Naïve and Treated Patients with Takayasu Arteritis
  • Abstract Number: 83
    Dysfunction of TRIM21 Promotes Aberrant Plasmablast Differentiation in Systemic Lupus Erythematosus Due to the Reduction of TRIM21-mediated Ubiquitylation of IRF5
  • Abstract Number: 1066
    Dysregulated IL-6 Dependent Dermal Adenosine Signaling via Adenosine A2A Receptor May Drive Fibrosis in Systemic Sclerosis
  • Abstract Number: 2027
    Dysregulation of Granulopoiesis in Systemic Lupus Erythematosus
Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences